Freddie Dear

About

Freddie Dear is a Principal at Monograph Capital. He was part of the founding team of portfolio company Ascend Advanced Therapies, where he held an operation role as VP, Corporate Development and remains an advisor to the company. He also sits on the board of portfolio company Nocion Therapeutics. Prior to Monograph Capital, he was an Investment Partner at Syncona, where he was involved in a number of investments including Quell Therapeutics and Forcefield Therapeutics, where he took operational roles in founding those businesses. Prior to Syncona, he was a member of the investment team at the Wellcome Trust. Freddie holds a BSc in Biochemistry from the University of Edinburgh

Source (opens in a new tab)